Prospective digital neurocognitive and patient-reported symptom monitoring in adults scheduled for CAR T-cell therapy: feasibility and exploratory patient-level observations from a single-center cohort
Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: To evaluate completion of individually tailored digital neurocognitive and symptom assessments in adults scheduled for CAR T-cell therapy and explore longitudinal changes in task-specific outcomes. METHODS: In this prospective single-center cohort (n = 33), NeuroCAT comprised 25 cognitive, visual, and graphomotor tasks and a symptom questionnaire at baseline (T0). At early post-infusion (T1) and pre-discharge (T2), investigators selected approximately eight tasks per participant. RESULTS: All 33 patients completed T0, and 30 (90.9%; Wilson 95% confidence interval, 76.4-96.9%) completed both T1 and T2 assessments. Two patients died before follow-up, and one did not undergo follow-up after interruption of the planned treatment pathway due to clinical instability. Paired quantitative T0/T2 observations were available for only 4-11 patients per task, with heterogeneous changes in task-specific indices and patient-reported symptoms. Among three patients with chart-documented grade 1 immune effector cell-associated neurotoxicity syndrome (ICANS), one had increased fatigue and neuropathic pain ratings and another had increased dizziness and concentration-difficulty ratings. Nonspecific symptom worsening was also observed in patients without ICANS. CONCLUSION: Completion of individually assigned follow-up assessments was high among enrolled patients. Nonrandom task selection, limited paired observations, unvalidated task indices, and nonspecific symptom changes preclude conclusions about ICANS detection or clinical utility. Prospective validation is required. RELEVANCE TO SUPPORTIVE CARE: Tailored digital assessments may support structured symptom documentation during CAR T-cell therapy, but patient burden and clinical value remain to be established.
Source: Supportive Care in Cancer
Authors: Anna Fleischer, Luna Dressler, Christofer Pohl, Onur Duman, Johannes Schobel, Carmen Sanges, Barbara Huber, Patrick-Pascal Strunz, Jessica Peter, Julia Mersi, Eleni Kakavela, K. Martin Kortüm, Johannes Waldschmidt, Sophia Danhof, Thomas Däullary, Leo Rasche, Johannes Düll, Götz Gelbrich, Hermann Einsele, Michael Hudecek, Max Topp, Imad Maatouk
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,690
OpenAlex ID: W7236693507
